Impact of Hemodialysis on Cutaneo-muscular Electrical Impedance

Last updated: June 30, 2023
Sponsor: Assistance Publique - Hôpitaux de Paris
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemodialysis

Treatment

N/A

Clinical Study ID

NCT04892745
APHP210098
2020-A03337-32
  • Ages 18-89
  • All Genders

Study Summary

The primary objective of this pilot study aims to describe the modifications of subcutaneous impedancemetry induced by dialysis.

As secondary objectives, the study aims to 1) describe the modifications of cutaneo-muscular impedancemetry induced by dialysis. 2) describe the relationship between modifications of subcutaneous impedancemetry induced by dialysis and - technical conditions of dialysis; - volemic parameters of dialysis; - evolution of liquid compartments in organism during dialysis; - volemic events or neuromuscular events. 3) describe the relationship between modifications of cutaneo-muscular impedancemetry induced by dialysis and 1) describe the modifications of cutaneo-muscular impedance induced by dialysis. 2) describe the relationship between modifications of subcutaneous impedancemetry induced by dialysis and - technical conditions of dialysis; - volemic parameters of dialysis; - evolution of liquid compartments in organism during dialysis; - volemic events or neuromuscular events.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient ⩾ 18 years;
  • Patient undergoing chronic dialysis in hemodialysis facility of Ambroise Paréhospital;
  • Patient has been informed and given no-opposition for participating to the study.

Exclusion

Exclusion Criteria:

  • Patient with a pacemaker or an implantable cardioverter defibrillator;
  • Patient under guardianship or curatorship;
  • Foreign patient under french AME scheme.

Study Design

Total Participants: 30
Study Start date:
September 29, 2021
Estimated Completion Date:
December 31, 2024

Study Description

The study will be realized in dialysis facility of Ambroise Paré hospital, APHP. The duration of enrollment of subjects will be 3 months, each enrolled patient will has 2 or 3 week's follow-up.

Connect with a study center

  • Service de Néphrologie, Hôpital Ambroise Paré, APHP

    Boulogne-Billancourt, 92100
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.